From neuroscience to neurology :neuroscience, molecular medicine, and the therapeutic transformation of neurology
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Amsterdam ; Boston
Name of Publisher, Distributor, etc.
Elsevier Academic Press
Date of Publication, Distribution, etc.
c2005
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
x, 513 p., ]24[ p. of plates : ill. )some col.( ; 29 cm.
GENERAL NOTES
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Seeing the brain so we can save it: the evolution of magnetic resonance -- Imaging as a clinical tool -- Advances in the acute treatment and secondary prevention of stroke -- Preserving function in acute nervous system injury -- Slowing the progression of multiple sclerosis -- The emergence of neurosurgical approaches to the treatment of epilepsy -- The neurobiology of migraine and transformation of headache therapy -- Botulinum toxins: transformation of a toxin into a treatment -- Prospects for slowing the progression of Parkinson's disease -- Current neurosurgical treatments for Parkinson's disease: where did they come from? -- Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies -- Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder -- Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety -- Genomics, proteomics, and neurology -- Neuroprotection: where are we going? -- Prospects for gene therapy for central nervous system disease -- Therapeutics development for hereditary neurological diseases -- Inherited channelopathies of the CNS: lessons for clinical neurology -- Inherited channelopathies of muscle: implications for therapy -- Transcriptional channelopathies of the nervous system: new targets for molecular medicine -- New molecular targets for the treatment of neuropathic pain -- Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain --Seeing the brain so we can save it: the evolution of magnetic resonance -- Imaging as a clinical tool -- Advances in the acute treatment and secondary prevention of stroke -- Preserving function in acute nervous system injury -- Slowing the progression of multiple sclerosis -- The emergence of neurosurgical approaches to the treatment of epilepsy -- The neurobiology of migraine and transformation of headache therapy -- Botulinum toxins: transformation of a toxin into a treatment -- Prospects for slowing the progression of Parkinson's disease -- Current neurosurgical treatments for Parkinson's disease: where did they come from? -- Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies -- Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder -- Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety -- Genomics, proteomics, and neurology -- Neuroprotection: where are we going? -- Prospects for gene therapy for central nervous system disease -- Therapeutics development for hereditary neurological diseases -- Inherited channelopathies of the CNS: lessons for clinical neurology -- Inherited channelopathies of muscle: implications for therapy -- Transcriptional channelopathies of the nervous system: new targets for molecular medicine -- New molecular targets for the treatment of neuropathic pain -- Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain --